Tsakanin rigakafin kwayar halitta
| Bayanai | |
|---|---|
| Ƙaramin ɓangare na | immune response (en) |
Magungunan rigakafi, wanda aka fi sani da rigakafin rigakafi na sel, amsawar rigakafi ce wacce ba ta dogara da samar da magungunan rigwa. Maimakon haka, rigakafin da aka yi da kwayoyin halitta shine kunna phagocytes, ƙwayoyin T na musamman na antigen (a.k.a. cytotoxic T lymphocytes), da kuma sakin cytokines daban-daban don mayar da martani ga antigen.
Tarihi
[gyara sashe | gyara masomin]A ƙarshen ƙarni na 19 na al'adar Hippocratic na magani, an yi tunanin tsarin rigakafi yana da rassa biyu: rigakafin humoral, wanda za'a iya samun aikin kariya na rigakafi a cikin jin dadi (ruwan jiki marasa sel ko plasma na jini) da rigakafin sel, wanda aikin kariya ya haɗa da sel. Kwayoyin BCD4 ko ƙwayoyin T mataimakin (wanda aka fi sani da ƙwayoyin Taimako na T) suna ba da kariya daga cututtuka daban-daban. Kwayoyin T marasa amfani, waɗanda ƙwayoyin T marasa girma ne waɗanda har yanzu ba su haɗu da antigen ba, ana canza su zuwa ƙwayoyin aiki na T bayan sun haɗu da ƙwayoyin antigen-presenting cells (APCs). Wadannan APCs, irin su macrophages, dendritic cells, da B cells, a wasu yanayi, suna ɗora antigenic peptide a kan manyan histocompatibility complex (MHC) na tantanin halitta, bi da bi suna gabatar da peptide ga masu karɓa akan T cells. Mafi mahimmancin waɗannan APCs sune Kwayoyin dendritic na musamman, waɗanda ke aiki ne kawai don cinyewa da gabatar da antigens.[1] Za'a iya sanya kwayoyin T masu aiki a cikin nau'o'i uku masu aiki, gano antigen peptide wanda ya samo asali ne daga nau'ikan pathogen daban-daban:
- Cytotoxic T cells, wanda ke kashe kwayoyin da suka kamu da cutar ta hanyar apoptosis ba tare da amfani da cytokines ba;
- Kwayoyin Th1, waɗanda ke aiki da farko don kunna macrophages;
- Kwayoyin Th2, waɗanda da farko suna aiki don motsa Kwayoyin B zuwa samar da magungunan rigakafi.[1]
A cikin wani tsari, Tsarin rigakafin jiki na halitta da Tsarin rigakafi na daidaitawa kowannensu yana dauke da abubuwan da ke tattare da rigakafin humoral da rigakafi ta sel. Wasu sassan da ke cikin kwayar halitta na tsarin rigakafin jiki, alal misali, sun haɗa da myeloid phagocytes, ƙwayoyin lymphoid (misali, ƙwayoyi na NK), da intraepithelial lymphocytes.[2]
Bayani game da shi
[gyara sashe | gyara masomin]Magungunan rigakafi na sel yana kare jiki ta hanyar:
- T-cell-mediated immunity (a.k.a. T-cell immunity): kunna antigen-specific cytotoxic T cells cewa iya haifar da apoptosis a cikin jiki sel nuna epitopes na kasashen waje antigen a kan su surface, kamar kwayoyin cuta, sel tare da intracellular, da kuma ciwon daji sel nuna tumor antigens.
- Macrophage da kwayoyin halitta masu kisan gilla (NK cell): ba da damar lalata pathogens ta hanyar ganewa da ɓoyewar ƙwayoyin cytotoxic (don ƙwayoyin NK) [3] da phagocytosis (don macrophages). [4]
- Motsa ƙwayoyin halitta don ɓoye nau'ikan cytokines waɗanda ke tasiri ga aikin sauran ƙwayoyin da ke da hannu a cikin martani na rigakafi da kuma martani na garkuwar jiki.[3][4]
Magungunan rigakafin da ke tattare da kwayoyin halitta da farko suna da niyya ga ƙwayoyin cuta waɗanda ke rayuwa a cikin phagocytes da waɗanda ke kamuwa da ƙwayoyin da ba na phagocytic ba. Yana da tasiri sosai wajen cire ƙwayoyin ƙwayoyin cuta, amma kuma yana shiga cikin karewa daga fungi, protozoa, ciwon daji, da ƙwayoyin intracellular. Har ila yau, yana taka muhimmiyar rawa wajen kin amincewa da transplantation. [ana buƙatar ƙa'ida] [ana buƙatar hujja][citation needed]
Ci gaban sel
[gyara sashe | gyara masomin]Dukkanin kwayoyin nau'in 1 suna fara ci gaban su daga kakannin lymphoid na yau da kullun (CLp) wanda ke bambanta don zama kakannin lymfoid na yau le kullun (CILp) da kakannin t-cell (Tp) ta hanyar tsarin lymphopoiesis.[5][6]
Ana iya rarrabe iyayen lymphoid na yau da kullun a cikin iyayen mai kisan kai (NKp) ko mai taimako na yau da kullum kamar iyayen lymfoid na halitta (CHILp). Za'a iya haifar da ƙwayoyin NKp don rarrabewa cikin ƙwayoyin kisan halitta ta hanyar IL-15. Ana iya haifar da ƙwayoyin CHILp don rarrabewa cikin ƙwayoyin ILC1 ta hanyar IL-15, cikin ƙwayohin ILC2 ta hanyar IL-7 ko ƙwayoyin InLC3 ta hanyar IL-7. [5][6]
Iyayen T-C na iya bambanta zuwa ƙwayoyin C+ marasa ilimi ko ƙwayoyinC+ marasa ilimi. Kwayoyin CD8+ marasa H na iya ci gaba da rarrabewa cikin sel na TC1 a kan bayyanar H="./Interleukin_12" id="mw7w" rel="mw:WikiLink" title="Interleukin 12">H="./Interleukin_1" id="mw8Q" rel="mw:WikiLink" title="Interleukin 1">IL-1, [IL-4] na iya haifar da bambancin zuwa sel na TTC2 kuma IL-1 ko IL-23 na iya haifar le bambancin zuwa cikin sel na C17. Kwayoyin CD4+ marasa amfani na iya bambanta zuwa sel na TH1 a kan bayyanar IL-12, TH2 a kan bayyanuwar IL-4 ko TH17 a kan bayyanarsa IL-1 ko IL-23.[5][6]
Rashin rigakafi na nau'i na 1
[gyara sashe | gyara masomin]Nau'in rigakafi na 1 yana amfani da nau'in nau'in 1 don kowane ɗayan waɗannan nau'ikan sel. Ta H ɓoye C="cx-link" data-linkid="168" href="./Interferon_gamma" id="mwAQY" rel="mw:WikiLink" title="Interferon gamma">interferon gamma da TNF, TH1, TC1, da ƙungiyar 1 ILCS suna kunna macrophages, suna canza su zuwa ƙwayoyin tasiri masu ƙarfi. Yana ba da kariya daga ƙwayoyin cuta, protozoa, da ƙwayoyin ƙwayoyin halitta. Har ila yau, yana da alhakin kumburi da rigakafin jiki tare da cututtuka irin su rheumatoid arthritis, Multiple sclerosis, da cututtukan kumburi duk suna da alaƙa da rigakafi na nau'in 1. Nau'in rigakafi na 1 ya ƙunshi waɗannan ƙwayoyin: [5]
- CD4+ TH sel
- c+ cytotoxic T cells (Tc1)
- T-Bet + interferon gamma samar da rukuni 1 ILCs (ILC1 da Natural killer cells)
An samo sH a cikin H="./Mice" id="mwASQ" rel="mw:WikiLink" title="Mice">beraye da H="./H" id="mwASU" rel="mw:WikiLink" title="Humans">mutane cewa cytokines na sa hannu ga waɗannan sel sune interferon gamma">interferon gamma da lymphotoxin alpha. Babban cytokine don bambanci a cikin sel na TH1 shine IL-12 wanda aka samar da Kwayoyin dendritic don mayar da martani ga kunna masu karɓar ganewa. T-bet wani abu ne na musamman na ƙwayoyin TH1. Kwayoyin TH1 kuma suna nunawa ta hanyar bayyanar masu karɓar chemokine wanda ke ba da damar motsi zuwa wuraren kumburi. Manyan masu karɓar chemokine a kan waɗannan sel sune CXCR3A da CCR5. Kwayoyin epithelial da keratinocytes suna iya ɗaukar ƙwayoyin TH1 zuwa wuraren kamuwa da cuta ta hanyar sakin chemokines CXCL9, CXCL10 da CXCL11 don mayar da martani ga interferon gamma. Bugu da ƙari, interferon gamma da waɗannan ƙwayoyin suka ɓoye yana da mahimmanci wajen rage ƙuƙwalwar ƙuƙwalwa a cikin shingen epithelial.[5]
Manazarta
[gyara sashe | gyara masomin]- 1 2 Ross Russell, Amy L; Dryden, Matthew S; Pinto, Ashwin A; Lovett, Joanna K (2018-10-03). "Lyme disease: diagnosis and management". Practical Neurology. 18 (6): 455–464. doi:10.1136/practneurol-2018-001998. ISSN 1474-7758. PMID 30282764. S2CID 52915054. Cite error: Invalid
<ref>tag; name "auto" defined multiple times with different content. - ↑ Romo, MR; Pérez-Martínez, D; Ferrer, CC (2016). "Innate immunity in vertebrates: an overview". Immunology (in Turanci). 148 (2): 125–139. doi:10.1111/imm.12597. PMC 4863567. PMID 26878338. S2CID 35251844.
- 1 2 Eissmann, Philipp. "Natural Killer Cells". British Society for Immunology. Retrieved 8 November 2018.
- 1 2 Saldana, José. "Macrophages". British Society for Immunology. Retrieved 8 November 2018.
- 1 2 3 4 5 Annunziato, F; Romagnani, C; Romagnani, S (March 2015). "The 3 major types of innate and adaptive cell-mediated effector immunity". The Journal of Allergy and Clinical Immunology. 135 (3): 626–35. Bibcode:2015JACI..135..626A. doi:10.1016/j.jaci.2014.11.001. PMID 25528359. Cite error: Invalid
<ref>tag; name "The 3 major types of innate and adaptive cell-mediated effector immunity." defined multiple times with different content. - 1 2 3 Kansler, Emily R.; Li, Ming O. (July 2019). "Innate lymphocytes—lineage, localization and timing of differentiation". Cellular & Molecular Immunology. 16 (7): 627–633. doi:10.1038/s41423-019-0211-7. PMC 6804950. PMID 30804475. Cite error: Invalid
<ref>tag; name "Innate lymphocytes-lineage, localization and timing of differentiation" defined multiple times with different content.